BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31926332)

  • 61. Angiotensin II-Induced vascular remodeling and hypertension involves cathepsin L/V- MEK/ERK mediated mechanism.
    Lu Y; Sun X; Peng L; Jiang W; Li W; Yuan H; Cai J
    Int J Cardiol; 2020 Jan; 298():98-106. PubMed ID: 31668507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Menadione-induced apoptosis in U937 cells involves Bid cleavage and stefin B degradation.
    Božič J; Bidovec K; Vizovišek M; Dolenc I; Stoka V
    J Cell Biochem; 2019 Jun; 120(6):10662-10669. PubMed ID: 30652348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cathepsin proteases mediate photoreceptor cell degeneration in Drosophila.
    Kinser RD; Dolph PJ
    Neurobiol Dis; 2012 Jun; 46(3):655-62. PubMed ID: 22426392
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activity of enzymes with different subcellular localization in the blood plasma of patients with aortic aneurysm.
    Gacko M; Ostapowicz R; Chrostek L; Worowska A; Kordecki K
    Med Sci Monit; 2005 Apr; 11(4):CR211-3. PubMed ID: 15795703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spatial localization of cathepsins: Implications in immune activation and resolution during infections.
    Anes E; Pires D; Mandal M; Azevedo-Pereira JM
    Front Immunol; 2022; 13():955407. PubMed ID: 35990632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Stroke; 2008 Sep; 39(9):2603-10. PubMed ID: 18635848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease.
    Sena BF; Figueiredo JL; Aikawa E
    Front Cardiovasc Med; 2017; 4():88. PubMed ID: 29379789
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages.
    Hughes CS; Colhoun LM; Bains BK; Kilgour JD; Burden RE; Burrows JF; Lavelle EC; Gilmore BF; Scott CJ
    Part Fibre Toxicol; 2016 Apr; 13():19. PubMed ID: 27108091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues.
    Droga-Mazovec G; Bojic L; Petelin A; Ivanova S; Romih R; Repnik U; Salvesen GS; Stoka V; Turk V; Turk B
    J Biol Chem; 2008 Jul; 283(27):19140-50. PubMed ID: 18469004
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells.
    Ling H; Vamvakas S; Busch G; Dämmrich J; Schramm L; Lang F; Heidland A
    Am J Physiol; 1995 Dec; 269(6 Pt 2):F911-7. PubMed ID: 8594887
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lysosome: the cell's 'suicidal bag' as a promising cancer target.
    Gyparaki MT; Papavassiliou AG
    Trends Mol Med; 2014 May; 20(5):239-41. PubMed ID: 24525251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.
    Yasuda Y; Li Z; Greenbaum D; Bogyo M; Weber E; Brömme D
    J Biol Chem; 2004 Aug; 279(35):36761-70. PubMed ID: 15192101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atherosclerosis and aortic aneurysm - is inflammation a common denominator?
    Peshkova IO; Schaefer G; Koltsova EK
    FEBS J; 2016 May; 283(9):1636-52. PubMed ID: 26700480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: a histology study.
    Xu N; Zhang YY; Lin Y; Bao B; Zheng L; Shi GP; Liu J
    Thromb Haemost; 2014 Feb; 111(2):333-44. PubMed ID: 24154706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
    Wuopio J; Hilden J; Bring C; Kastrup J; Sajadieh A; Jensen GB; Kjøller E; Kolmos HJ; Larsson A; Jakobsen JC; Winkel P; Gluud C; Carlsson AC; Ärnlöv J
    Atherosclerosis; 2018 Nov; 278():97-102. PubMed ID: 30261474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cathepsin Protease Inhibition Reduces Endometriosis Lesion Establishment.
    Porter KM; Wieser FA; Wilder CL; Sidell N; Platt MO
    Reprod Sci; 2016 May; 23(5):623-9. PubMed ID: 26482207
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mammalian legumain - A lysosomal cysteine protease with extracellular functions?
    Lunde NN; Bosnjak T; Solberg R; Johansen HT
    Biochimie; 2019 Nov; 166():77-83. PubMed ID: 31181234
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lysosomes and lysosomal cathepsins in cell death.
    Repnik U; Stoka V; Turk V; Turk B
    Biochim Biophys Acta; 2012 Jan; 1824(1):22-33. PubMed ID: 21914490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma Cystatin B Association With Abdominal Aortic Aneurysms and Need for Later Surgical Repair: A Sub-study of the VIVA Trial.
    Wang Y; Liu CL; Lindholt JS; Shi GP; Zhang J
    Eur J Vasc Endovasc Surg; 2018 Dec; 56(6):826-832. PubMed ID: 30262158
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
    Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
    Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.